<DOC>
	<DOCNO>NCT01822990</DOCNO>
	<brief_summary>Circulating anti-beta2-glycoprotein antibody associate coronary artery disease peripheral arterial disease . This auto-antibodies could activate endothelial cell lead expression leukocyte adhesion molecule increase release pro-inflammatory cytokine . On hand , endothelial dysfunction atherosclerotic patient act primary pathogenic event , occur structural change evident angiogram ultrasound scan . Loss endothelial normal function cause vasoconstriction , local coagulation alteration increase arterial wall proliferation . This situation attribute reduction nitric oxide bioactivity , increase oxygen-free radical formation context pro-inflammatory status find atherosclerosis . Hypothesis : Circulating Anti-beta2-glycoprotein I antibody could associate endothelial dysfunction nitric oxide metabolism disruption en patient peripheral arterial disease .</brief_summary>
	<brief_title>Circulating Anti-Beta2-glycoprotein Antibodies Endothelial Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<mesh_term>Beta 2-Glycoprotein I</mesh_term>
	<criteria>Male gender Peripheral arterial disease diagnosis Intermittent claudication . Hemodynamic confirmation disease noninvasive vascular study . Autoimmune disease Previous revascularization ischemic limb . Ischemic ulcer Previous history organ transplant . Treatment immunosuppressor</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Anti-beta2-glycoprotein antibody</keyword>
	<keyword>Peripheral arterial disease</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Nitric oxide</keyword>
	<keyword>Endothelial dysfunction</keyword>
</DOC>